3i Group plc ("3i"), a world leader in private equity and venture capital, will today host a seminar for analysts and investors to discuss its pan-European Buyout business.
The presentation will be available onhttp://www.3igroup.com/shareholders/presreports/pres/ from 3:00pm today.
For information please contact:
|Douwe Cosijn||Head of IR, 3i Group plc||020 7975 3283|
Notes to editors
3i is a world leader in private equity and venture capital. We focus on buyouts, growth capital and venture capital and invest across Europe, in the United States and in Asia.
Our competitive advantage comes from our international network and the strength and breadth of our relationships in business. These underpin the value that we deliver to our portfolio and to our shareholders.
3i's European Buyout business
The 3i European Buyout business is a leader in the European mid-market. Managing over €3.5bn invested in over 100 companies across Europe, the business invests in all sectors, with a particular focus on media, healthcare and business support services.
Some recent investments include NCP - UK - £555m, Keolis - France - €540m - passenger transport, Betapharm - Germany - €300m - pharmaceuticals, Hobbs - UK - €158m - women's fashion retailer and Crown Media - pay TV channels - €185m. Some recent successful exits include Westminster Healthcare - UK - €751m, Pinewood Shepperton flotation - UK - €75m, and Travelex - UK foreign exchange service - £1bn, YBR Group sale - directories business - €1.8bn.